https://india-pharma.gsk.com/en-in/ 2026-06-02T15:13:39.553Z https://india-pharma.gsk.com/en-in/company/ 2026-06-02T14:33:25.337Z https://india-pharma.gsk.com/en-in/company/purpose-strategy-and-culture/ 2026-06-02T15:14:18.13Z https://india-pharma.gsk.com/en-in/company/gsk-at-a-glance/ 2026-06-02T14:33:49.117Z https://india-pharma.gsk.com/en-in/company/discover-gsk-in-india/ 2026-06-02T14:33:46.99Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/ 2026-06-02T14:33:48.52Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/rskarnad/ 2026-06-02T14:33:47.843Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/subesh-williams/ 2026-06-02T14:33:46.487Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/dr-sunita-maheshwari/ 2026-06-02T14:34:02.22Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/manu-anand/ 2026-06-02T14:34:01.577Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/bhushan-akshikar/ 2026-06-02T14:34:04.123Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/mr-somasundaram-palamadairamaswamy/ 2026-06-02T14:34:03.07Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/mr-anup-wadhawan/ 2026-06-02T14:34:03.597Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/ronojit-biswas/ 2026-06-02T14:34:19.56Z https://india-pharma.gsk.com/en-in/company/policy-positions/ 2026-06-02T14:34:22.587Z https://india-pharma.gsk.com/en-in/company/welcome-to-gsk-s-century-of-trust-gallery/ 2026-06-02T14:34:20.057Z https://india-pharma.gsk.com/en-in/products/ 2026-06-02T14:34:21.117Z https://india-pharma.gsk.com/en-in/products/prescribing-information/ 2026-06-02T14:34:23.47Z https://india-pharma.gsk.com/en-in/products/prescribing-information-tab/ 2026-06-02T14:34:31.553Z https://india-pharma.gsk.com/en-in/products/healthcare/ 2026-06-02T15:13:38.527Z https://india-pharma.gsk.com/en-in/products/terms-and-conditions/ 2026-06-02T14:34:30.72Z https://india-pharma.gsk.com/en-in/products/regulator/ 2026-06-02T15:13:37.603Z https://india-pharma.gsk.com/en-in/products/report-a-possible-side-effect/ 2026-06-02T15:13:37.11Z https://india-pharma.gsk.com/en-in/careers/ 2026-06-02T14:34:43.727Z https://india-pharma.gsk.com/en-in/careers/lifeatgsk/ 2026-06-02T15:05:33.453Z https://india-pharma.gsk.com/en-in/careers/experienced-professionals/ 2026-06-02T14:34:42.717Z https://india-pharma.gsk.com/en-in/careers/early-careers-at-gsk-india/ 2026-06-02T14:34:43.213Z https://india-pharma.gsk.com/en-in/careers/how-we-hire/ 2026-06-02T14:34:45.067Z https://india-pharma.gsk.com/en-in/careers/how-we-hire/frequently-asked-questions/ 2026-06-02T14:35:08.497Z https://india-pharma.gsk.com/en-in/careers/how-we-hire/fraudulent-internet-recruitment-activities/ 2026-06-02T14:35:07.66Z https://india-pharma.gsk.com/en-in/investors/ 2026-06-02T14:35:11Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/ 2026-06-02T14:35:09.69Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/policies/ 2026-06-02T14:35:10.35Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/notices/ 2026-06-02T14:35:23.68Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/ 2026-06-02T14:35:22.073Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/events-calendar/ 2026-06-02T14:35:21.657Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/shareholding-pattern/ 2026-06-02T14:35:22.61Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/code-of-internal-procedures-and-conduct-for-regulating-monitoring-and-reporting-of-trading-by-insiders/ 2026-06-02T14:35:21.103Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/memorandum-and-articles-of-association/ 2026-06-02T14:35:32.79Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/newspaper-publication/ 2026-06-02T14:35:33.67Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/annual-return/ 2026-06-02T14:35:33.24Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/investors-grievances/ 2026-06-02T14:35:34.46Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/unpaid-unclaimed-dividend/ 2026-06-02T15:05:32.073Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/corporate-governance-report/ 2026-06-02T14:35:56.903Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/sebi-lodr-regulations/ 2026-06-02T15:05:32.993Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/download-forms/ 2026-06-02T15:05:32.527Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/annual-compliance-report/ 2026-06-02T14:35:56.487Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/related-party-transactions/ 2026-06-02T14:35:55.967Z https://india-pharma.gsk.com/en-in/investors/annual-reports/ 2026-06-02T15:15:04.41Z https://india-pharma.gsk.com/en-in/investors/quarterly-results/ 2026-06-02T15:43:03.42Z https://india-pharma.gsk.com/en-in/investors/analyst-meets/ 2026-06-02T15:15:03.92Z https://india-pharma.gsk.com/en-in/media/ 2026-06-02T15:15:02.893Z https://india-pharma.gsk.com/en-in/media/press-releases/ 2026-06-02T15:15:02.32Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-june-30-2022/ 2026-06-02T15:15:19.89Z https://india-pharma.gsk.com/en-in/media/press-releases/media-release-q1-of-2022-23/ 2026-06-02T15:15:18.49Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-full-year-ended-march-31-2022/ 2026-06-02T15:15:19.437Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-launches-once-daily-single-inhaler-triple-therapy-for-copd-patients-for-the-first-time-in-india/ 2026-06-02T15:15:18.987Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-and-ms-dhoni-team-up-for-6-in-1-vaccination-awareness-campaign/ 2026-06-02T15:42:59.677Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-september-30-2021/ 2026-06-02T15:43:02.373Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-june-30-2021/ 2026-06-02T15:15:41.483Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-and-full-year-ended-march-31-2021/ 2026-06-02T15:43:01.803Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-ended-december-31-2020/ 2026-06-02T15:15:38.51Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-path-and-bharat-biotech-sign-product-transfer-agreement-to-help-ensure-long-term-supply-of-ground-breaking-malaria-vaccine/ 2026-06-02T15:15:40.903Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-ended-september-30-2020/ 2026-06-02T15:43:20.47Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-ended-june-30-2020/ 2026-06-02T15:15:54.54Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant-in-2021-to-support-multiple-covid-19-vaccine-collaborations/ 2026-06-02T15:43:02.917Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-and-full-year-ended-march-31-2020/ 2026-06-02T15:15:54.987Z https://india-pharma.gsk.com/en-in/media/press-releases/appointments-to-the-glaxosmithkline-pharmaceuticals-ltd-board/ 2026-06-02T15:15:54.093Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-delivers-strong-financials-led-by-pharma-growth/ 2026-06-02T15:43:18.617Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-september-30-2022/ 2026-06-02T15:16:20.563Z https://india-pharma.gsk.com/en-in/media/press-releases/new-data-show-shingrix-can-provide-at-least-10-years-of-protection-against-shingles-in-adults-aged-50-years-and-over/ 2026-06-02T15:16:21.11Z https://india-pharma.gsk.com/en-in/media/press-releases/continued-momentum-across-general-medicines-and-specialty/ 2026-06-02T15:43:21.683Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-launches-shingrix-in-india-a-vaccine-for-the-prevention-of-shingles-in-adults-aged-50-years-and-above/ 2026-06-02T15:43:21.08Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-reported-improved-profitability-with-continued-momentum-across-general-medicines-and-specialty-declares-annual-dividend-of-rs-32/ 2026-06-02T15:41:39.26Z https://india-pharma.gsk.com/en-in/media/press-releases/amitabh-bachchan-partners-with-gsk-for-shingles-awareness-and-prevention/ 2026-06-02T15:41:21.833Z https://india-pharma.gsk.com/en-in/media/press-releases/general-medicines-delivers-4-revenue-growth-despite-nlem-impact-along-with-a-sequential-recovery-in-the-vaccines-business/ 2026-06-02T15:41:22.303Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-registers-5-growth/ 2026-06-02T15:41:23.597Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-gsk-announces-its-financial-results-for-the-third-quarter-ended-31st-december-2023/ 2026-06-02T15:17:47.583Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceutical-limited-reports-strong-double-digit-growth-and-improved-profitability-for-the-quarter/ 2026-06-02T15:41:40.777Z https://india-pharma.gsk.com/en-in/media/press-releases/gsks-new-campaign-asks-parents-to-support-their-childrens-future-with-7-crucial-vaccinations/ 2026-06-02T15:43:34.857Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-reports-continued-growth-and-profitability-for-the-quarter/ 2026-06-02T15:42:09.01Z https://india-pharma.gsk.com/en-in/media/press-releases/yeh-science-hai-amitabh-bachchan-and-manoj-pahwa-partner-with-gsk-for-new-shingles-awareness-and-prevention-campaign/ 2026-06-02T15:18:57.933Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-crosses-rs1000-crore-in-revenue-from-operations/ 2026-06-02T15:41:54.09Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-gsk-delivers-strong-q3-performance-with-double-digit-growth/ 2026-06-02T15:41:40.333Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-and-yuva-unstoppable-transform-education-with-100th-smart-classroom-in-nashik/ 2026-06-02T15:41:22.82Z https://india-pharma.gsk.com/en-in/media/press-releases/data-at-the-end-of-a-long-term-study-shows-shingrix-continues-to-provide-high-protection-against-shingles-in-adults-aged-50-and-over-for-more-than-a-decade/ 2026-06-02T15:43:22.12Z https://india-pharma.gsk.com/en-in/media/press-releases/most-people-over-50-in-india-unaware-of-shingles-disease-despite-being-at-risk1/ 2026-06-02T15:41:24.087Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-reports-topline-growth-and-profitability-for-full-year-ended-31-march-2025/ 2026-06-02T15:17:48.963Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-delivers-sustained-profitability-for-quarter-ended-june-30-2025-continues-to-invest-in-key-portfolios/ 2026-06-02T15:43:34.473Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-forays-into-oncology-in-india-with-jemperli-and-zejula-bringing-precision-therapies-for-gynaecological-cancers/ 2026-06-02T15:18:58.477Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-s-nashik-facility-achieves-global-bsi-amr-kitemark-certification/ 2026-06-02T15:41:57.023Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-delivers-competitive-performance-in-q2fy26-ebidta-margin-grows-by-250-basis-points/ 2026-06-02T15:41:54.637Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-crosses-inr-1-000-crores-in-topline-plus81-as-key-portfolios-deliver/ 2026-06-02T15:41:55.013Z https://india-pharma.gsk.com/en-in/media/press-releases/shingles-disrupts-life-yet-half-of-ageing-indians-with-chronic-conditions-don-t-talk-about-prevention-with-their-doctors1/ 2026-06-02T15:42:06.58Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-india-builds-momentum-with-innovative-portfolio-reports-continued-profitable-growth-for-year-ended-31st-march-2026/ 2026-06-02T15:43:34.037Z https://india-pharma.gsk.com/en-in/media/media-contacts/ 2026-06-02T15:43:35.263Z https://india-pharma.gsk.com/en-in/media/in-focus/ 2026-06-02T15:41:41.217Z https://india-pharma.gsk.com/en-in/media/in-focus/corporate/ 2026-06-02T15:41:41.953Z https://india-pharma.gsk.com/en-in/media/in-focus/csr/ 2026-06-02T15:47:27.383Z https://india-pharma.gsk.com/en-in/media/in-focus/disease-awareness/ 2026-06-02T15:47:27.927Z https://india-pharma.gsk.com/en-in/responsibility/ 2026-06-02T15:51:41.247Z https://india-pharma.gsk.com/en-in/responsibility/inclusion/ 2026-06-02T15:47:26.783Z https://india-pharma.gsk.com/en-in/responsibility/ethical-standards/ 2026-06-02T15:47:26.297Z https://india-pharma.gsk.com/en-in/responsibility/ethical-standards/engaging-with-healthcare-professionals/ 2026-06-02T15:47:43.9Z https://india-pharma.gsk.com/en-in/responsibility/ethical-standards/engaging-with-healthcare-professionals/tov-disclosure-report-gsk-india/ 2026-06-02T15:47:45.6Z https://india-pharma.gsk.com/en-in/responsibility/corporate-social-responsibility/ 2026-06-02T15:47:45.01Z https://india-pharma.gsk.com/en-in/responsibility/environment-health-safety/ 2026-06-02T15:47:43.19Z https://india-pharma.gsk.com/en-in/terms-of-use/ 2026-06-02T15:47:42.74Z https://india-pharma.gsk.com/en-in/legal-disclaimer/ 2026-06-02T15:47:58.79Z https://india-pharma.gsk.com/en-in/cookie-policy/ 2026-06-02T15:48:00.167Z https://india-pharma.gsk.com/en-in/accessibility/ 2026-06-02T15:48:00.603Z https://india-pharma.gsk.com/en-in/search/ 2026-06-02T15:47:59.813Z https://india-pharma.gsk.com/en-in/error-404/ 2026-06-02T15:47:58.483Z https://india-pharma.gsk.com/en-in/sitemap/ 2026-06-02T15:48:19.773Z https://india-pharma.gsk.com/en-in/contact-us/ 2026-06-02T15:48:17.753Z https://india-pharma.gsk.com/en-in/innovation/ 2026-06-02T15:48:16.687Z https://india-pharma.gsk.com/en-in/innovation/therapeutic-areas/ 2026-06-02T15:48:18.35Z https://india-pharma.gsk.com/en-in/innovation/trials/ 2026-06-02T15:48:17.29Z https://india-pharma.gsk.com/en-in/innovation/trials/provision-of-unlicensed-medicines-for-unmet-medical-needs/ 2026-06-02T15:48:32.107Z https://india-pharma.gsk.com/en-in/innovation/trials/data-transparency/ 2026-06-02T15:51:46.567Z https://india-pharma.gsk.com/en-in/innovation/trials/diversity-in-clinical-trials/ 2026-06-02T15:48:31.583Z https://india-pharma.gsk.com/en-in/locations/ 2026-06-02T15:51:39.923Z https://india-pharma.gsk.com/en-in/digital-sustainability/ 2026-06-02T15:51:40.473Z